October 26, 2023
Skye is limitless
Unlocking the pharmaceutical potential of the endocannabinoid system
We are a pharmaceutical company developing proprietary molecules to treat diseases involving inflammatory, fibrotic, and metabolic conditions.
Our focus is on advancing first- and only-in-class drugs with potential to provide new therapeutic outcomes for diseases with significant prevalence and unmet needs.